![]() Other Issues: |
Contents: Volume 21, Supplement 3 July 2006
[Index by Author]
|
||||
| |
|||||
| Managing Cardiovascular Risk in Renal Transplant Recipients: The Role of Everolimus | |||||
This supplement has been sponsored by an unrestricted educational grant from Novartis Pharma AG, Basel, Switzerland. |
|||||
| |
|||||
Table of Contents (PDF)
